FIGURE 2 TYPES OF WEB 2 TOOLS USED FOR HEALTH 2

FIGURE 3 BENEFITS OF HEALTH 2.0 FOR HEALTHCARE INDUSTRY AND PATIENTS

FIGURE 4 SHIFT OF COMMUNICATION MODEL FROM TRADITIONAL MEDIA TO SOCIAL MEDIA

FIGURE 5 RELATIVE TIME OF INITIATING SOCIAL MEDIA EFFORTS BY TOP 10 PHARMACEUTICAL PLAYERS

FIGURE 6 YOUTUBE AND TWITTER ENTRY TIME OF TOP 5 PHARMACEUTICAL PLAYERS

FIGURE 7 NUMBER OF VIEWS/FOLLOWERS OF KEY SOCIAL MEDIA TOOLS BY TOP 5 PHARMACEUTICAL PLAYERS

FIGURE 8 OBJECTIVES OF SOCIAL MEDIA USAGE AND PHARMACEUTICAL PLAYERS' INVOLVEMENT

FIGURE 9 RELATIVE ADOPTION OF SOCIAL MEDIA STRATEGIES BY TOP 5 PHARMA PLAYERS

FIGURE 10 QUALITATIVE ROI FROM SOCIAL MEDIA TO PHARMACEUTICAL INDUSTRY

FIGURE 11 TWITTER INVOLVEMENT OF TOP 20 PHARMACEUTICAL COMPANIES

FIGURE 12 OBJECTIVES OF TOP 20 PHARMACEUTICAL COMPANIES ON TWITTER

FIGURE 13 FACEBOOK INVOLVEMENT OF TOP 20 PHARMACEUTICAL COMPANIES

FIGURE 14 OBJECTIVES OF TOP 20 PHARMACEUTICAL COMPANIES ON FACEBOOK

FIGURE 15 YOUTUBE INVOLVEMENT OF TOP 20 PHARMACEUTICAL COMPANIES

FIGURE 16 OBJECTIVES OF TOP 20 PHARMACEUTICAL COMPANIES ON YOUTUBE

FIGURE 17 BLOGS INVOLVEMENT OF TOP 20 PHARMACEUTICAL COMPANIES

FIGURE 18 STEPS TO INITIATE SOCIAL MEDIA INVOLVEMENT

FIGURE 19 RELATIVE INVOLVEMENT IN SELECTING RIGHT SOCIAL MEDIA MIX

FIGURE 20 BENEFITS FOR PFIZER AFTER COLLABORATION WITH SERMO

FIGURE 21 SOCIAL MEDIA PLATFORMS

FIGURE 22 RELATIVE INVOLVEMENT IN ENLARGING USER BASE

FIGURE 23 BENEFITS OF HIGHER TRAFFIC FOR DIFFERENT STAKEHOLDERS

FIGURE 24 PROCESS OF STARTING SOCIAL MEDIA CONVERSATION WITH CONSUMERS

FIGURE 25 RELATIVE INVOLVEMENT IN DEVELOPING BRAND PERCEPTIONS